Rating History for Aslan Pharma (ASLN) by Roth/MKM
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/31/2023 | Dylan Dupuls | New Coverage | Buy (N/A) |
15.00 (N/A) |
3.91 (0.60) |
-84.65% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/31/2023 | Dylan Dupuls | New Coverage | Buy (N/A) |
15.00 (N/A) |
3.91 (0.60) |
-84.65% | Details |